CNTY-813
Asset
iPSC-derived islet replacement therapy for type 1 diabetes
- Stage
- Preclinical
- Modality
- Cell therapy
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Type 1 diabetes
Preclinical, globenewswire.com, 2 Oct 2026
In the full profile
- Owner and partners1
- Competitors2
Every asset’s record: target, stage, trials and the evidence behind it.